Osteogenic Differentiation of Human Amniotic Fluid Mesenchymal Stem Cells Is Determined by Epigenetic ChangesMonika Glemžaitė, Rūta Navakauskienė|Stem Cells International|2016Cited by 26
Pharmaceutical Drug Metformin and MCL1 Inhibitor S63845 Exhibit Anticancer Activity in Myeloid Leukemia Cells via Redox RemodelingGiedrė Valiulienė, Rūta Navakauskienė|Molecules|2021Cited by 15
Effects of human placenta cryopreservation on molecular characteristics of placental mesenchymal stromal cellsRūta Navakauskienė, Volodymyr Shablii|Frontiers in Bioengineering and Biotechnology|2023Cited by 11
The Effect of Angiotensin II, Retinoic Acid, EGCG, and Vitamin C on the Cardiomyogenic Differentiation Induction of Human Amniotic Fluid-Derived Mesenchymal Stem CellsMonika Gasiūnienė, Rūta Navakauskienė|International Journal of Molecular Sciences|2020Cited by 10
Effect of 3D Spheroid Culturing on NF-κB Signaling Pathway and Neurogenic Potential in Human Amniotic Fluid Stem CellsGiedrė Valiulienė, Rūta Navakauskienė|International Journal of Molecular Sciences|2023Cited by 3